Review
BibTex RIS Cite
Year 2017, Volume: 4 Issue: 1, 1 - 11, 31.01.2017
https://doi.org/10.17546/msd.286924

Abstract

A possible alternate pathway for intravascular thrombosis - Investigation of the circumstantial evidence by microfluidics

Year 2017, Volume: 4 Issue: 1, 1 - 11, 31.01.2017
https://doi.org/10.17546/msd.286924

Abstract

In light of the literature,
in this hypothesis, we aimed to settle up an experimental procedure and
possible mechanism for bacteremia induced disseminated intravascular
coagulation via QA.
Bacteremia resulting in sepsis and disseminated
intravascular coagulation (DIC) are known for thrombosis and coagulopathy. DIC,
which results in simultaneous activation and consumption of coagulation
factors, could be investigated using microfluidics as a tool. Here, we propose
the hypothesis that bacteria (e.g. E.coli) mediated DIC results from a
collective phenomenon called “quorum acting” (QA). If our hypothesis is true,
than the coagulation cascade will be activated before systemic inflammation. To
check for QA we propose to perform a hemodynamic experiment where blood is
controllably flown over E.coli clusters in a microfluidic device.
Further, manipulation of the physical properties (flow rate mimicking condition
like venous stasis) and chemical properties (hyperglycaemia as in uncontrolled
diabetes mellitus) of blood could be done using microfluidic device to mimic
their  etiopathogenesis  and to validate our proposed mechanism that
quorum acting mediated DIC occurs rapidly in venous stasis and uncontrolled
diabetes mellitus respectively.

There are 0 citations in total.

Details

Subjects Health Care Administration
Journal Section Review Article
Authors

Siddhartha Das

Amlan Barai This is me

Publication Date January 31, 2017
Published in Issue Year 2017 Volume: 4 Issue: 1

Cite

APA Das, S., & Barai, A. (2017). A possible alternate pathway for intravascular thrombosis - Investigation of the circumstantial evidence by microfluidics. Medical Science and Discovery, 4(1), 1-11. https://doi.org/10.17546/msd.286924
AMA Das S, Barai A. A possible alternate pathway for intravascular thrombosis - Investigation of the circumstantial evidence by microfluidics. Med Sci Discov. January 2017;4(1):1-11. doi:10.17546/msd.286924
Chicago Das, Siddhartha, and Amlan Barai. “A Possible Alternate Pathway for Intravascular Thrombosis - Investigation of the Circumstantial Evidence by Microfluidics”. Medical Science and Discovery 4, no. 1 (January 2017): 1-11. https://doi.org/10.17546/msd.286924.
EndNote Das S, Barai A (January 1, 2017) A possible alternate pathway for intravascular thrombosis - Investigation of the circumstantial evidence by microfluidics. Medical Science and Discovery 4 1 1–11.
IEEE S. Das and A. Barai, “A possible alternate pathway for intravascular thrombosis - Investigation of the circumstantial evidence by microfluidics”, Med Sci Discov, vol. 4, no. 1, pp. 1–11, 2017, doi: 10.17546/msd.286924.
ISNAD Das, Siddhartha - Barai, Amlan. “A Possible Alternate Pathway for Intravascular Thrombosis - Investigation of the Circumstantial Evidence by Microfluidics”. Medical Science and Discovery 4/1 (January 2017), 1-11. https://doi.org/10.17546/msd.286924.
JAMA Das S, Barai A. A possible alternate pathway for intravascular thrombosis - Investigation of the circumstantial evidence by microfluidics. Med Sci Discov. 2017;4:1–11.
MLA Das, Siddhartha and Amlan Barai. “A Possible Alternate Pathway for Intravascular Thrombosis - Investigation of the Circumstantial Evidence by Microfluidics”. Medical Science and Discovery, vol. 4, no. 1, 2017, pp. 1-11, doi:10.17546/msd.286924.
Vancouver Das S, Barai A. A possible alternate pathway for intravascular thrombosis - Investigation of the circumstantial evidence by microfluidics. Med Sci Discov. 2017;4(1):1-11.